Effectiveness of Nonpharmacologic Treatments of Burning Mouth Syndrome: A Systematic Review

Aims: To assess the efficacy of nonpharmacologic treatments for burning mouth syndrome (BMS). Methods: PubMed, Scopus, Web of Science, and the Cochrane Central Register of Controlled Trials were systematically searched. Reference lists from the latest systematic reviews (2015 to 2020) on BMS treatment in the PubMed, Scopus, Web of Science, and CochraneLibrary databases were also scrutinized. Randomized controlled trials (RCTs) or clinical controlled trials (CCTs) in English were considered eligible. Trials on photobiomodulation were excluded to avoid redundancy with recent publications. Risk of bias was established through the Cochrane Risk of Bias tool for RCTs and the Risk of Bias in Nonrandomized Studies of Interventions (ROBINS-I) tool for CCTs. Results: This review included 27 RCTs and 6 open clinical trials (OCTs) describing 14 different nonpharmacologic interventions. Eleven trials experimented with 600 to 800 mg/day of alpha-lipoic acid for 30 to 120 days, with 7 placebo-controlled studies showing significant pain relief. Four trials tested topical and systemic capsaicin for 7 to 30 days, with 2 placebo-controlled studies revealing significant efficacy. Four of the 5 trials testing acupuncture offered favorable evidence of pain relief. Two trials reported significant pain relief after a 2- to 3-month regimen with tongue protectors and showed no difference after aloe vera addition. Short-term pain relief was reported in anecdotal placebo-controlled trials deploying tocopherol, catuama, ultramicronized palmitoylethanolamide, group psychotherapy, cognitive therapy, and repetitive transcranial magnetic stimulation of the prefrontal cortex. Most therapies were safe. Conclusion: Evidence was collected from highly biased, short-term, heterogenous studies mainly focused on BMS-related pain, with scarce data on quality of life, psychologic status, dysgeusia, and xerostomia. Long-term effectiveness of nonpharmacologic treatments should be further investigated, with a more rigorous, bias-proof study design.

alternative medicine; burning mouth syndrome; clinical trials; non-pharmacological; treatment

1. Périer JM, Boucher Y. History of burning mouth syndrome (1800–1950): A review. Oral Dis 2019;25:425–438.

2. Merskey H, Bogduk N. Classification of Chronic Pain, ed 2. Seattle: International Association for the Study of Pain, 1994.

3. Scala A, Checchi L, Montevecchi M, Marini I, Giamberardino

A. Update on burning mouth syndrome: Overview and patient management. Crit Rev Oral Biol Med 2003;14:275–291.

4. International Classification of Orofacial Pain, 1st edition (ICOP). Cephalalgia 2020;40:129–221.

5. Jääskeläinen SK, Woda A. Burning mouth syndrome. Cephalalgia 2017;37:627–647.

6. Bender SD. Burning mouth syndrome. Dent Clin North Am 2018;62:585–596.

7. van der Ploeg HM, van der Wal N, Eijkman MA, van der Waal I. Psychological aspects of patients with burning mouth syndrome. Oral Surg Oral Med Oral Pathol 1987;63:664–668.

8. Kim MJ, Kim J, Kho HS. Comparison between burning mouth syndrome patients with and without psychological problems. Int J Oral Maxillofac Surg 2018;47:879–887.

9. Koike K, Shinozaki T, Hara K, et al. Immune and endocrine function in patients with burning mouth syndrome. Clin J Pain 2014;30:168–173.

10. Lauria G, Majorana A, Borgna M, et al. Trigeminal small-fiber sensory neuropathy causes burning mouth syndrome. Pain 2005;115:332–337.

11. Hagelberg N, Forssell H, Rinne JO, et al. Striatal dopamine D1 and D2 receptors in burning mouth syndrome. Pain 2003;101:149–154.

12. Koszewicz M, Mendak M, Konopka T, Koziorowska-Gawron E, Budrewicz S. The characteristics of autonomic nervous system disorders in burning mouth syndrome and Parkinson disease. J Orofac Pain 2012;26:315–320.

13. Imamura Y, Shinozaki T, Okada-Ogawa A, et al. An updated review on pathophysiology and management of burning mouth syndrome with endocrinological, psychological and neuro-pathic perspectives. J Oral Rehabil 2019;46:574–587.

14. Miller CS, Farag AM, Chmieliauskaite M, et al. Is burning mouth a syndrome or a disorder? A commentary. Oral Surg Oral Med Oral Pathol Oral Radiol 2019;127:361–363.

15. Poon R, Su N, Ching V, Darling M, Grushka M. Reduction in unstimulated salivary flow rate in burning mouth syndrome. BrDent J 2014;217:E14.

16. Spadari F, Venesia P, Azzi L, et al. Low basal salivary flow and burning mouth syndrome: New evidence in this enigmatic pathology. J Oral Pathol Med 2015;44:229–233.

17. Kisely S, Forbes M, Sawyer E, Black E, Lalloo R. A systematic review of randomized trials for the treatment of burning mouth syndrome. J Psychosom Res 2016;86:39–46.

18. Zakrzewska J, Buchanan JAG. Burning mouth syndrome. BMJ Clin Evid 2016;2016:1301.

19. de Souza IF, Mármora BC, Rados PV, Visioli F. Treatment modalities for burning mouth syndrome: A systematic review. Clin Oral Investig 2018;22:1893–1905.

20. Tu TTH, Takenoshita M, Matsuoka H, et al. Current manage-ment strategies for the pain of elderly patients with burning mouth syndrome: A critical review. Biopsychosoc Med 2019;13:1.

21. Moher, D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: The PRISMA Statement. PLoS Med 2009;6:e1000097.

22. Zhang W, Hu L, Zhao W, Yan Z. Effectiveness of photobiomodulation in the treatment of primary burning mouth syndrome—A systematic review and meta-analysis. Lasers Med Sci 2021;36:239–248.

23. de Pedro M, López-Pintor RM, de la Hoz-Aizpurua JL Casañas E, Hernández G. Efficacy of low-level laser therapy for the therapeutic management of neuropathic orofacial pain: A systematic review. J Oral Facial Pain Headache 2020;34:13–30.

24. Sterne JAC, Savovic` J, Page MJ, et al. RoB 2: A revised tool for assessing risk of bias in randomised trials. BMJ 2019;366:l4898.

25. Sterne JA, Hernán MA, Reeves BC, et al. ROBINS-I: A tool for assessing risk of bias in non-randomised studies of interventions. BMJ 2016;355:i4919.

26. Femiano F, Gombos F, Scully C, Busciolano M, De Luca P. Burning mouth syndrome (BMS): Controlled open trial of the efficacy of alphalipoic acid (thioctic acid) on symptomatology. Oral Dis 2000;6:274–277.

27. Femiano F. Burning mouth syndrome (BMS): An open trial of comparative efficacy of alphalipoic acid (thioctic acid) with other therapies. Minerva Stomatol 2002;51:405–409.

28. Femiano F, Scully C. Burning mouth syndrome (BMS): Double blind controlled study of alphalipoic acid (thioctic acid) thera-py. J Oral Pathol Med 2002;31:267–269.

29. Femiano F, Gombos F, Scully C. Burning mouth syndrome: Open trial of psychotherapy alone, medication with alphali-poic acid (thioctic acid), and combination therapy. Med Oral 2004;9:8–13.

30. Carbone M, Pentenero M, Carrozzo M, Ippolito A, Gandolfo S. Lack of efficacy of alphalipoic acid in burning mouth syn-drome: A double-blind, randomized, placebo-controlled study. Eur J Pain 2009;13:492–496.

31. Cavalcanti DR, da Silveira FR. Alpha lipoic acid in burning mouth syndrome—A randomized double-blind placebo-controlled trial. J Oral Pathol Med 2009;38:254–261.

32. López-Jornet P, Camacho-Alonso F, Leon-Espinosa S. Efficacy of alpha lipoic acid in burning mouth syndrome: A randomized, placebo-treatment study. J Oral Rehabil 2009;36:52–57.

33. Marino R, Torretta S, Capaccio P, Pignataro L, Spadari F. Different therapeutic strategies for burning mouth syndrome: Preliminary data. J Oral Pathol Med 2010;39:611–616.

34. López-D’alessandro E, Escovich L. Combination of alpha lipoic acid and gabapentin, its efficacy in the treatment of burning mouth syndrome: A randomized, double-blind, placebo controlled trial. Med Oral Patol Oral Cir Bucal 2011;16:e635–e640.

35. Palacios-Sánchez B, Moreno-López LA, Cerero-Lapiedra R, Llamas-Martínez M, Esparza-Gómez G. Alpha lipoic acid efficacy in burning mouth syndrome. A controlled clinical trial. Med Oral Patol Oral Cir Bucal 2015;20:e435–e440.

36. Çinar LS, Kartal D, Pergel T, Borlu M. Effectiveness and safety of clonazepam, pregabalin, and alpha lipoic acid for the treatment of burning mouth syndrome. Erciyes Med J 2018;40:35–38.

37. Kang JH. Influences of systemic oxidative stress levels on therapeutic efficiency of tocopherol in treatment of burning mouth syndrome: Preliminary study. J Oral Pathol Med 2019;48:s20.

38. Anand P, Bley K. Topical capsaicin for pain management: Therapeutic potential and mechanisms of action of the new high-concentration capsaicin 8% patch. Br J Anaesth 2011;107:490–502.

39. Petruzzi M, Lauritano D, De Benedittis M, Baldoni M, Serpico R. Systemic capsaicin for burning mouth syndrome: Short-term results of a pilot study. J Oral Pathol Med 2004;33:111–114.

40. Silvestre FJ, Silvestre-Rangil J, Tamarit-Santafé C, Bautista D. Application of a capsaicin rinse in the treatment of burning mouth syndrome. Med Oral Patol Oral Cir Bucal 2012;17:e1–e4.

41. Azzi L, Croveri F, Pasina L, et al. A “burning” therapy for burning mouth syndrome: Preliminary results with the administration of topical capsaicin. J Biol Regul Homeost Agents 2017;31(suppl 2):s89–s95.

42. Jørgensen MR, Pedersen AM. Analgesic effect of topical oral capsaicin gel in burning mouth syndrome. Acta Odontol Scand 2017;75:130–136.

43. Bessho K, Okubo Y, Hori S, Murakami K, Iizuka T. Effectiveness of kampo medicine (sai-boku-to) in treatment of patients with glossodynia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998;86:682–686.

44. Sardella A, Lodi G, Demarosi F, Tarozzi M, Canegallo L, Carrassi A. Hypericum perforatum extract in burning mouth syndrome: A randomized placebo-controlled study. J Oral Pathol Med 2008;37:395–401.

45. Spanemberg JC, Cherubini K, de Figueiredo MA, Gomes AP, Campos MM, Salum FG. Effect of an herbal compound for treatment of burning mouth syndrome: Randomized, controlled, double-blind clinical trial. Oral Surg Oral Med Oral Pathol Oral Radiol 2012;113:373–377.

46. Cano-Carrillo P, Pons-Fuster A, López-Jornet P. Efficacy of lycopene-enriched virgin olive oil for treating burning mouth syndrome: A double-blind randomised. J Oral Rehabil 2014;41:296–305.

47. Silva LA, Siqueira JT, Teixeira MJ, Siqueira SR. The role of xe-rostomia in burning mouth syndrome: A case-control study. Arq Neuropsiquiatr 2014;72:91–98.

48. Valenzuela S, Pons-Fuster A, López-Jornet P. Effect of a 2%topical chamomile application for treating burning mouth syndrome: A controlled clinical trial. J Oral Pathol Med 2016;45:528–533.

49. Ottaviani G, Rupel K, Gobbo M, et al. Efficacy of ultramicron-ized palmitoylethanolamide in burning mouth syndrome-affected patients: A preliminary randomized double-blind controlled trial. Clin Oral Investig 2019;23:2743–2750.

50. Scardina GA, Ruggieri A, Provenzano F, Messina P. Burning mouth syndrome: Is acupuncture a therapeutic possibility? Br Dent J 2010;209:E2.

51. Sardella A, Lodi G, Tarozzi M, Varoni E, Franchini R, Carrassi A. Acupuncture and burning mouth syndrome: A pilot study. Pain Pract 2013;13:627–632.

52. Franco FR, Castro LA, Borsatto MC, Silveira EA, Ribeiro-Rotta RF. Combined acupuncture and auriculotherapy in burning mouth syndrome treatment: A preliminary singlearm clinical trial. J Altern Complement Med 2017;23:126–134.

53. Jurisic Kvesic A, Zavoreo I, Basic Kes V, et al. The effectiveness of acupuncture versus clonazepam in patients with burning mouth syndrome. Acupunct Med 2015;33:289–292.

54. Zavoreo I, Basic-Kes V, Sikora M, Boras VV, Gabric D, Rogulj AA. Efficacy of acupuncture and vitamin C in burning mouth syndrome—A pilot study. Acta Stomatologica Croatica 2017;51:81–82.

55. Miziara ID, Filho BC, Oliveira R, Rodrigues dos Santos RM. Group psychotherapy: An additional approach to burning mouth syndrome. J Psychosom Res 2009;67:443–448.

56. Bergdahl J, Anneroth G, Perris H. Cognitive therapy in the treatment of patients with resistant burning mouth syndrome: Acontrolled study. J Oral Pathol Med 1995;24:213–215.

57. Umezaki Y, Badran BW, DeVries WH, Moss J, Gonzales T, George MS. The efficacy of daily prefrontal repetitive transcranial magnetic stimulation (rTMS) for burning mouth syndrome (BMS): A randomized controlled single-blind study. Brain Stimul 2016;9:234–242.

58. Baeken C, Brem AK, Arns M, et al. Repetitive transcranial magnetic stimulation treatment for depressive disorders: Current knowledge and future directions. Curr Opin Psychiatry 2019;32:409–415.

59. Liampas A, Rekatsina M, Vadalouca A, Paladini A, Varrassi G, Zis P. Non-pharmacological management of painful peripheral neuropathies: A systematic review. Adv Ther 2020;37:4096–4106.

60. López-Jornet P, Camacho-Alonso F, Andujar-Mateos P. A prospective, randomized study on the efficacy of tongue protector in patients with burning mouth syndrome. Oral Dis 2011;17:277–282.

61. López-Jornet P, Camacho-Alonso F, Molino-Pagan D. Prospective, randomized, double-blind, clinical evaluation of Aloe vera Barbadensis, applied in combination with a tongue protector to treat burning mouth syndrome. J Oral Pathol Med 2013;42:295–301.

62. McMillan R, Forssell H, Buchanan JA, Glenny AM, Weldon JC, Zakrzewska JM. Interventions for treating burning mouth syndrome. Cochrane Database Syst Rev 2016;11:CD002779.